150 related articles for article (PubMed ID: 28927789)
1. Anticancer efficacy of p-dodecylaminophenol against high-risk and refractory neuroblastoma cells in vitro and in vivo.
Takahashi N; Koyama S; Hasegawa S; Yamasaki M; Imai M
Bioorg Med Chem Lett; 2017 Oct; 27(20):4664-4672. PubMed ID: 28927789
[TBL] [Abstract][Full Text] [Related]
2. p-Dodecylaminophenol derived from the synthetic retinoid, fenretinide: antitumor efficacy in vitro and in vivo against human prostate cancer and mechanism of action.
Takahashi N; Watanabe Y; Maitani Y; Yamauchi T; Higashiyama K; Ohba T
Int J Cancer; 2008 Feb; 122(3):689-98. PubMed ID: 17955489
[TBL] [Abstract][Full Text] [Related]
3. The anti-tumor agent, p-DDAP potently suppresses proliferation through apoptosis in human neuroblastoma NB-39-nu cells.
Takahashi N; Egawa R; Imai M; Takahashi K; Ohba T; Imaizumi M
Cancer Lett; 2010 Nov; 297(2):252-8. PubMed ID: 20580487
[TBL] [Abstract][Full Text] [Related]
4. Sparstolonin B, a novel plant derived compound, arrests cell cycle and induces apoptosis in N-myc amplified and N-myc nonamplified neuroblastoma cells.
Kumar A; Fan D; Dipette DJ; Singh US
PLoS One; 2014; 9(5):e96343. PubMed ID: 24788776
[TBL] [Abstract][Full Text] [Related]
5. Growth inhibition and mechanism of action of p-dodecylaminophenol against refractory human pancreatic cancer and cholangiocarcinoma.
Imai M; Takahashi N
Bioorg Med Chem; 2012 Apr; 20(8):2520-6. PubMed ID: 22440084
[TBL] [Abstract][Full Text] [Related]
6. Potent anticancer activities of novel aminophenol analogues against various cancer cell lines.
Ohba T; Yamauch T; Higashiyama K; Takahashi N
Bioorg Med Chem; 2007 Jan; 15(2):847-53. PubMed ID: 17092729
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of p-dodecylaminophenol on the invasiveness of human fibrosarcoma cell line HT1080.
Takahashi N; Takeda K; Imai M
Bioorg Med Chem; 2013 Oct; 21(19):6015-21. PubMed ID: 23953690
[TBL] [Abstract][Full Text] [Related]
8. Tryptanthrin induces growth inhibition and neuronal differentiation in the human neuroblastoma LA-N-1 cells.
Liao X; Leung KN
Chem Biol Interact; 2013 Apr; 203(2):512-21. PubMed ID: 23500671
[TBL] [Abstract][Full Text] [Related]
9. The small molecule Bcl-2/Mcl-1 inhibitor TW-37 shows single-agent cytotoxicity in neuroblastoma cell lines.
Klenke S; Akdeli N; Stelmach P; Heukamp L; Schulte JH; Bachmann HS
BMC Cancer; 2019 Mar; 19(1):243. PubMed ID: 30885150
[TBL] [Abstract][Full Text] [Related]
10. Novel anthranilamide-pyrazolo[1,5-a]pyrimidine conjugates modulate the expression of p53-MYCN associated micro RNAs in neuroblastoma cells and cause cell cycle arrest and apoptosis.
Ramaiah MJ; Pushpavalli SN; Lavanya A; Bhadra K; Haritha V; Patel N; Tamboli JR; Kamal A; Bhadra U; Pal-Bhadra M
Bioorg Med Chem Lett; 2013 Oct; 23(20):5699-706. PubMed ID: 23992861
[TBL] [Abstract][Full Text] [Related]
11. Arsenic trioxide inhibits neuroblastoma growth in vivo and promotes apoptotic cell death in vitro.
Ora I; Bondesson L; Jönsson C; Ljungberg J; Pörn-Ares I; Garwicz S; Pâhlman S
Biochem Biophys Res Commun; 2000 Oct; 277(1):179-85. PubMed ID: 11027660
[TBL] [Abstract][Full Text] [Related]
12. Berberine inhibits human neuroblastoma cell growth through induction of p53-dependent apoptosis.
Choi MS; Yuk DY; Oh JH; Jung HY; Han SB; Moon DC; Hong JT
Anticancer Res; 2008; 28(6A):3777-84. PubMed ID: 19189664
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of the selective MDM2 antagonist nutlin-3 against chemoresistant neuroblastoma with wild-type p53.
Van Maerken T; Ferdinande L; Taildeman J; Lambertz I; Yigit N; Vercruysse L; Rihani A; Michaelis M; Cinatl J; Cuvelier CA; Marine JC; De Paepe A; Bracke M; Speleman F; Vandesompele J
J Natl Cancer Inst; 2009 Nov; 101(22):1562-74. PubMed ID: 19903807
[TBL] [Abstract][Full Text] [Related]
14. Tumorigenic proteins upregulated in the MYCN-amplified IMR-32 human neuroblastoma cells promote proliferation and migration.
Zaatiti H; Abdallah J; Nasr Z; Khazen G; Sandler A; Abou-Antoun TJ
Int J Oncol; 2018 Mar; 52(3):787-803. PubMed ID: 29328367
[TBL] [Abstract][Full Text] [Related]
15. Synergistic efficacy of a novel combination therapy controls growth of Bcl-x(L) bountiful neuroblastoma cells by increasing differentiation and apoptosis.
Mohan N; Banik NL; Ray SK
Cancer Biol Ther; 2011 Nov; 12(9):846-54. PubMed ID: 21878749
[TBL] [Abstract][Full Text] [Related]
16. Low dose of arsenic trioxide inhibits multidrug resistant-related P-glycoprotein expression in human neuroblastoma cell line.
Liu L; Li Y; Xiong X; Qi K; Zhang C; Fang J; Guo H
Int J Oncol; 2016 Dec; 49(6):2319-2330. PubMed ID: 27840903
[TBL] [Abstract][Full Text] [Related]
17. Vasoactive intestinal peptide decreases MYCN expression and synergizes with retinoic acid in a human MYCN-amplified neuroblastoma cell line.
Chevrier L; Meunier AC; Cochaud S; Muller JM; Chadéneau C
Int J Oncol; 2008 Nov; 33(5):1081-9. PubMed ID: 18949372
[TBL] [Abstract][Full Text] [Related]
18. Proapoptotic compound ARC targets Akt and N-myc in neuroblastoma cells.
Radhakrishnan SK; Halasi M; Bhat UG; Kurmasheva RT; Houghton PJ; Gartel AL
Oncogene; 2008 Jan; 27(5):694-9. PubMed ID: 17724478
[TBL] [Abstract][Full Text] [Related]
19. Isatin inhibits proliferation and induces apoptosis of SH-SY5Y neuroblastoma cells in vitro and in vivo.
Song J; Hou L; Ju C; Zhang J; Ge Y; Yue W
Eur J Pharmacol; 2013 Feb; 702(1-3):235-41. PubMed ID: 23376416
[TBL] [Abstract][Full Text] [Related]
20. Metabolic Evaluation of MYCN-Amplified Neuroblastoma by 4-[
Li C; Huang S; Guo J; Wang C; Huang Z; Huang R; Liu L; Liang S; Wang H
Mol Imaging Biol; 2019 Dec; 21(6):1117-1126. PubMed ID: 30850970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
